NCT03416465

Brief Summary

The Purpose of MGPEC\_ONCO is to see if patient consult their general practitioner during the management of their cancer, especially before hospitalization. The study concerns not planned hospitalizations in medicine service. Before leaving hospital, the patient completes the survey, other data are taken in patient record

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
197

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 31, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

May 16, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2019

Completed
Last Updated

August 12, 2020

Status Verified

August 1, 2020

Enrollment Period

1 year

First QC Date

January 24, 2018

Last Update Submit

August 11, 2020

Conditions

Oncologic Disorders

Keywords

hospitalizationcancergeneral practitioner

Outcome Measures

Primary Outcomes (1)

  • Patients in unscheduled hospitalization

    Percentage of patients in unscheduled hospitalization who have seen their general practitioner

    1 day

Interventions

medical questionnaireBEHAVIORAL

The patient will complete a questionnaire of 10 questions before leaving hospital. This questionnaire concerns the care pathway for hospitalized patients.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any patient hospitalized in a medical service in an unscheduled way

You may qualify if:

  • Patient undergoing oncology treatment or ≤ 1 year of the latest oncology treatments
  • Patient hospitalized in a medical service in an unscheduled way
  • Age \> or = 18 years old
  • Patient informed and not opposed to the study
  • Patient able and agreeing to follow all study procédures
  • Patient must be affiliated to a social security system

You may not qualify if:

  • Patient hospitalized in surgery and continuing care services
  • Patient deprived of liberty or under supervision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de Cancérologie de Lorraine

Vandœuvre-lès-Nancy, France

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • HENRY ALINE

    Institut de Cancérologie de Lorraine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2018

First Posted

January 31, 2018

Study Start

May 16, 2018

Primary Completion

May 16, 2019

Study Completion

May 16, 2019

Last Updated

August 12, 2020

Record last verified: 2020-08

Locations

FR(1)